Alma Lasers responds to Lumenis patent claim

Alma Lasers Ltd. has filed a response denying all Lumenis' patent infringement claims. Alma Lasers will vigorously defend its position.

"Alma Lasers continues to build momentum in the marketplace due to our innovation, value and high customer service," stated Howard Kelly, CEO of Alma Lasers. "It is unfortunate that certain competitors resort to litigation to compensate for their failings in the marketplace."

Previously, Lumenis tried to enforce two of the same patents it is now asserting against Alma in a lawsuit against another company and failed. With respect to those two patents, a federal district judge denied Lumenis' Motion for Preliminary Injunction, and questioned the validity of a Lumenis asserted claim in a published opinion. Lumenis ultimately settled that case before trial.

Alma Lasers continues to stand behind all of its products and their warranties. Our customers and prospective customers can be assured that this dispute will not impact their use of any Alma product.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Lumenis Inc.. (2019, June 17). Alma Lasers responds to Lumenis patent claim. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/2007/10/15/31177.aspx.

  • MLA

    Lumenis Inc.. "Alma Lasers responds to Lumenis patent claim". News-Medical. 22 December 2024. <https://www.news-medical.net/news/2007/10/15/31177.aspx>.

  • Chicago

    Lumenis Inc.. "Alma Lasers responds to Lumenis patent claim". News-Medical. https://www.news-medical.net/news/2007/10/15/31177.aspx. (accessed December 22, 2024).

  • Harvard

    Lumenis Inc.. 2019. Alma Lasers responds to Lumenis patent claim. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/2007/10/15/31177.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lumenis to discuss different treatment options for laryngeal cancer at 2009 AAO-HNS